Sanofi (SNY) Restructuring Costs (2009 - 2026)

Sanofi (SNY) has 18 years of Restructuring Costs data on file, last reported at -$139.3 million in Q1 2026.

• Quarterly Restructuring Costs fell 26.14% year-over-year to -$139.3 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was -$2.5 billion (down 13.17% YoY) and the FY2025 annual result came in at $1.3 billion, down 11.2% from the prior year.
• Restructuring Costs grew to -$139.3 million in Q1 2026 per SNY's latest filing, from -$1.3 billion in the prior quarter.
• The five-year high for Restructuring Costs was -$110.4 million in Q1 2025, with the low at -$1.5 billion in Q4 2024.
• Average Restructuring Costs over 5 years is -$519.5 million, with a median of -$367.9 million recorded in 2025.
• Year-over-year, Restructuring Costs slumped 538.96% in 2023 and soared 83.44% in 2025.
• Sanofi's Restructuring Costs stood at -$173.4 million in 2022, then tumbled by 538.96% to -$1.1 billion in 2023, then sank by 34.61% to -$1.5 billion in 2024, then gained by 11.2% to -$1.3 billion in 2025, then jumped by 89.48% to -$139.3 million in 2026.
• Business Quant data shows SNY's Restructuring Costs at -$139.3 million in Q1 2026, -$1.3 billion in Q4 2025, and -$703.8 million in Q3 2025.